Literature DB >> 17525953

Discordant lymphatic drainage patterns revealed by serial lymphoscintigraphy in cutaneous head and neck malignancies.

Alliric I Willis1, John A Ridge.   

Abstract

BACKGROUND: We analyzed the variability and accuracy of sentinel lymph node (SLN) identification by lymphoscintigraphy performed preoperatively and repeated on the day of operation in patients with melanoma or Merkel cell cancer.
METHODS: Twenty-five prospectively studied patients had lymphoscintigraphy prior to and on the day of operation. Discordance between lymphoscintograms was defined as change in location of SLN or failure to identify a SLN by one of the studies.
RESULTS: In 22 of 24 assessable cases (92%), SLNs were excised. Preoperative lymphoscintigraphy was correct in 19 of 22 (86%) cases. Day of operation lymphoscintigraphy was correct in 20 of 22 (91%) cases. SLN location was as classically described in 24 of 25 (96%) cases. Discordance between lymphoscintigraphy studies was 32% (8/25 patients). Half with discordant migration (8%) yielded metastases in basins not identified by day of operation lymphoscintigraphy but demonstrated by preoperative lymphoscintigraphy.
CONCLUSIONS: Head and neck lymphatic drainage patterns not only vary between patients but also can vary with time for a single patient.

Entities:  

Mesh:

Year:  2007        PMID: 17525953     DOI: 10.1002/hed.20631

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  15 in total

1.  Malignant melanoma of the head and neck: a brief review of pathophysiology, current staging, and management.

Authors:  Christian Hasney; R Brent Butcher; Ronald G Amedee
Journal:  Ochsner J       Date:  2008

Review 2.  Focus on Merkel cell carcinoma: diagnosis and staging.

Authors:  Marion Grandhaye; Pedro Gondim Teixeira; Philippe Henrot; Olivier Morel; Francois Sirveaux; Jean-Luc Verhaeghe; Alain Blum
Journal:  Skeletal Radiol       Date:  2015-01-30       Impact factor: 2.199

3.  Selective radiotherapy for the treatment of head and neck Merkel cell carcinoma.

Authors:  Benjamin Lok; Sabrina Khan; Robert Mutter; Jeffrey Liu; Ryan Fields; Melissa Pulitzer; Weiji Shi; Zhigang Zhang; Dennis Kraus; David Pfister; Klaus J Busam; Isaac Brownell; Nancy Lee
Journal:  Cancer       Date:  2011-12-16       Impact factor: 6.860

4.  Tumor location predicts survival in cutaneous head and neck melanoma.

Authors:  Warren H Tseng; Steve R Martinez
Journal:  J Surg Res       Date:  2010-11-10       Impact factor: 2.192

5.  Geographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanoma.

Authors:  Steve R Martinez; Dhruvil R Shah; Emanual Maverakis; Anthony D Yang
Journal:  J Surg Oncol       Date:  2012-06-04       Impact factor: 3.454

6.  Sentinel lymph node biopsy in head and neck melanoma*.

Authors:  G Giudice; S Leuzzi; F Robusto; V Ronghi; E Nacchiero; G Giardinelli; G Di Gioia; L Ragusa; M Pascone
Journal:  G Chir       Date:  2014 May-Jun

7.  Correlation between theoretical anatomical patterns of lymphatic drainage and lymphoscintigraphy findings during sentinel node detection in head and neck melanomas.

Authors:  Mónica Vidal; Sergi Vidal-Sicart; Ferran Torres; Diana Milena Ruiz; Pilar Paredes; Francesca Pons
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-19       Impact factor: 9.236

8.  A practical update of surgical management of merkel cell carcinoma of the skin.

Authors:  Patricia Tai
Journal:  ISRN Surg       Date:  2013-01-30

9.  Radiotherapy for metastatic merkel cell carcinoma: a review of the literature.

Authors:  Luluel Khan; Elizabeth A Barnes
Journal:  J Skin Cancer       Date:  2012-07-02

10.  Sentinel Lymph Node Biopsy in Head and Neck Melanoma: Long-term Outcomes, Prognostic Value, Accuracy, and Safety.

Authors:  John E Hanks; Kevin J Kovatch; S Ahmed Ali; Emily Roberts; Alison B Durham; Joshua D Smith; Carol R Bradford; Kelly M Malloy; Philip S Boonstra; Christopher D Lao; Scott A McLean
Journal:  Otolaryngol Head Neck Surg       Date:  2020-02-11       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.